
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.
Luckily for you, we built StockStory to help you separate the good from the bad. That said, here are three cash-producing companies that don’t make the cut and some better opportunities instead.
Travel + Leisure (TNL)
Trailing 12-Month Free Cash Flow Margin: 10.9%
Formerly known as Wyndham Destinations, Travel + Leisure (NYSE: TNL) is a global vacation company that provides travelers with vacation ownership, exchange, and travel services.
Why Do We Pass on TNL?
- Demand for its offerings was relatively low as its number of tours conducted has underwhelmed
- Diminishing returns on capital from an already low starting point show that neither management’s prior nor current bets are going as planned
- 8× net-debt-to-EBITDA ratio makes lenders less willing to extend additional capital, potentially necessitating dilutive equity offerings
At $73.02 per share, Travel + Leisure trades at 9.7x forward P/E. If you’re considering TNL for your portfolio, see our FREE research report to learn more.
Builders FirstSource (BLDR)
Trailing 12-Month Free Cash Flow Margin: 5.8%
Headquartered in Irving, TX, Builders FirstSource (NYSE: BLDR) is a construction materials manufacturer that offers a variety of lumber and lumber-related building products.
Why Are We Out on BLDR?
- Sales tumbled by 6.9% annually over the last two years, showing market trends are working against it during this cycle
- Earnings per share decreased by more than its revenue over the last two years, showing each sale was less profitable
- Diminishing returns on capital suggest its earlier profit pools are drying up
Builders FirstSource is trading at $74 per share, or 16.1x forward P/E. To fully understand why you should be careful with BLDR, check out our full research report (it’s free).
Bruker (BRKR)
Trailing 12-Month Free Cash Flow Margin: 1.5%
With roots dating back to the pioneering days of nuclear magnetic resonance technology, Bruker (NASDAQ: BRKR) develops and manufactures high-performance scientific instruments that enable researchers and industrial analysts to explore materials at microscopic, molecular, and cellular levels.
Why Does BRKR Give Us Pause?
- Core business is underperforming as its organic revenue has disappointed over the past two years, suggesting it might need acquisitions to stimulate growth
- Efficiency has decreased over the last five years as its adjusted operating margin fell by 7.7 percentage points
- Waning returns on capital imply its previous profit engines are losing steam
Bruker’s stock price of $58.23 implies a valuation ratio of 26.8x forward P/E. Check out our free in-depth research report to learn more about why BRKR doesn’t pass our bar.
High-Quality Stocks for All Market Conditions
ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.
Find out which 5 stocks it’s flagging this month — FREE. Get Our Top 5 Growth Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,552% between June 2020 and June 2025). Find your next big winner with StockStory today.